Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinflunine + gemcitabine versus carboplatin + gemcitabine in cisplatin-unfit metastatic urothelial carcinoma
2013-002417-35Phase 2Completed
- Sponsor
- Karolinska University Hospital
- Start
- Sep 2013
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in transitional cell carcinoma (TCC) comparing Vinflunine + gemcitabine with Carboplatin + gemcitabine (2 arms). Primary endpoints: Progression-free survival and Disease control rate. Started Sep 2013; status: completed.
02
Drugs
vinfluninegemcitabinecarboplatin
03
Conditions
transitional cell carcinoma (TCC)
Beyond the preview
Go deeper on 2013-002417-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002417-35.